Your browser doesn't support javascript.
loading
Pre-existing inflammatory disease predicts cutaneous immunotherapy toxicity development: A multi-institutional cohort study.
Wan, Guihong; Nguyen, Nga; Leung, Bonnie W; Rashdan, Hannah; Tang, Kimberly; Roster, Katie; Collier, Michael R; Ugwu-Dike, Pearl O; Raval, Neel S; Alexander, Nora A; Jairath, Ruple; Phillipps, Jordan; Amadife, Munachimso; Zhang, Shijia; Gusev, Alexander; Chen, Steven T; Reynolds, Kerry L; LeBoeuf, Nicole R; Kwatra, Shawn G; Semenov, Yevgeniy R.
  • Wan G; Department of Dermatology, Massachusetts General Hospital, Boston, Massachusetts; Department of Dermatology, Harvard Medical School, Boston, Massachusetts.
  • Nguyen N; Department of Dermatology, Massachusetts General Hospital, Boston, Massachusetts.
  • Leung BW; Department of Dermatology, Massachusetts General Hospital, Boston, Massachusetts.
  • Rashdan H; Department of Dermatology, Massachusetts General Hospital, Boston, Massachusetts.
  • Tang K; Department of Dermatology, Massachusetts General Hospital, Boston, Massachusetts.
  • Roster K; Department of Dermatology, Massachusetts General Hospital, Boston, Massachusetts.
  • Collier MR; Department of Dermatology, Massachusetts General Hospital, Boston, Massachusetts.
  • Ugwu-Dike PO; Department of Dermatology, Massachusetts General Hospital, Boston, Massachusetts.
  • Raval NS; Department of Dermatology, Massachusetts General Hospital, Boston, Massachusetts.
  • Alexander NA; Department of Dermatology, Massachusetts General Hospital, Boston, Massachusetts.
  • Jairath R; Department of Dermatology, Massachusetts General Hospital, Boston, Massachusetts.
  • Phillipps J; Department of Dermatology, Massachusetts General Hospital, Boston, Massachusetts.
  • Amadife M; Department of Dermatology, Massachusetts General Hospital, Boston, Massachusetts.
  • Zhang S; Department of Dermatology, Massachusetts General Hospital, Boston, Massachusetts.
  • Gusev A; Department of Medicine, Dana Farber Cancer Institute, Boston, Massachusetts.
  • Chen ST; Department of Dermatology, Massachusetts General Hospital, Boston, Massachusetts.
  • Reynolds KL; Division of Oncology, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts.
  • LeBoeuf NR; Department of Dermatology, Dana Farber Cancer Institute, Boston, Massachusetts.
  • Kwatra SG; Department of Dermatology, Johns Hopkins University, Baltimore, Maryland.
  • Semenov YR; Department of Dermatology, Massachusetts General Hospital, Boston, Massachusetts; Department of Dermatology, Harvard Medical School, Boston, Massachusetts. Electronic address: ysemenov@mgh.harvard.edu.
J Am Acad Dermatol ; 90(2): 418-420, 2024 Feb.
Article en En | MEDLINE | ID: mdl-37838257
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Enfermedades de la Piel / Antineoplásicos Inmunológicos / Neoplasias Límite: Humans Idioma: En Año: 2024 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Enfermedades de la Piel / Antineoplásicos Inmunológicos / Neoplasias Límite: Humans Idioma: En Año: 2024 Tipo del documento: Article